Teva Pharmaceuticals To Expand in Canada With $6M Grant
05/28/2010
"Teva's high potent product manufacturing facility expansion in Stouffville, Ontario will enable use to secure Canadian and export mandates for high-quality, value-priced generic medicines," said Barry Fishman, president and CEO of Teva Canada Limited. "This partnership with the Ontario government to construct an advanced manufacturing facility will increase Teva Canada's capabilities and capacity and allow us to retain and grow high-value jobs in Ontario."
The same day the expansion was announced, Ontario Premier Dalton McGuinty met with scientists from Israel's Weizman Institute of Science to discuss new partnership opportunities. Among the Institute's research are ways to eliminate famine.
"Teva Pharmaceuticals is a perfect example of the kind of partner we're looking for in Israel," McGuinty said.
Project Announcements
Swiss-Based Temenos Plans Orlando, Florida, Operations
06/23/2025
Phoenix Manufacturing Expands Glasgow, Missouri, Operations
06/23/2025
Otto Aviation Plans Jacksonville, Florida, Manufacturing Operations
06/20/2025
AMI Metals Expands Spokane, Washington, Production Operations
06/20/2025
Newly Weds Foods Plans Dyersburg, Tennessee, Production Operations
06/20/2025
Yaskawa American Expands Franklin, Wisconsin, Headquarters Operations
06/19/2025
Most Read
-
20th Annual Area Development Gold and Silver Shovel Awards
Q2 2025
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
The New Math Behind Mexico and U.S. Manufacturing Decisions
Q2 2025